Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Williams

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2021
Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of PneumonitisMark R Jackson, Katrina Stevenson, Sandeep K Chahal, et al.
Neuro-Oncology|April 30, 2020
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trialCatherine Hanna, Kathreena M Kurian, Karin Williams, et al.
Developmental Biology|February 10, 2007
Directed differentiation of embryonic stem cells into bladder tissueSiam Oottamasathien, YongQing Wang, Karin Williams, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signalingVasudha Tandon, Alessandra Fistrovich, Joaquina Nogales, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2021
Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of PneumonitisMark R Jackson, Katrina Stevenson, Sandeep K Chahal, et al.
Neuro-Oncology|April 30, 2020
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trialCatherine Hanna, Kathreena M Kurian, Karin Williams, et al.
Developmental Biology|February 10, 2007
Directed differentiation of embryonic stem cells into bladder tissueSiam Oottamasathien, YongQing Wang, Karin Williams, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signalingVasudha Tandon, Alessandra Fistrovich, Joaquina Nogales, et al.
Pageof 3